Stock Track | I-Mab Shares Plummet 5.30% Following Board and Advisory Appointments

Stock Track

Aug 26, 2025

Shares of I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, plummeted 5.30% during intraday trading on Monday, following the announcement of new appointments to its Board of Directors and Scientific Advisory Board, as well as the formation of a Research and Development Committee.

The company revealed early Monday that it had appointed Dr. Robert Lenz, Ms. Xin Liu, and Dr. Sean Cao to its Board of Directors. Additionally, I-Mab announced the formation of a Research and Development Committee and the appointment of Dr. Ken Takeshita to its Scientific Advisory Board. While these changes were positioned as enhancements to the company's expertise and strategic focus, investors appeared to react negatively to the news.

The sharp decline in I-Mab's stock price suggests that the market may be uncertain about how these leadership changes will impact the company's future direction and performance. Investors might be concerned about potential shifts in strategy or execution that could result from the new appointments. Despite the company's emphasis on strengthening its R&D capabilities and board expertise, the market's immediate reaction indicates a level of skepticism or caution among shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1100375914"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100375914\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100375914?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-26 04:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100375914","market":"nz","top_or_hot":-1,"title":"Stock Track | I-Mab Shares Plummet 5.30% Following Board and Advisory Appointments","media":"Stock Track","content":"<p>Shares of I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, plummeted 5.30% during intraday trading on Monday, following the announcement of new appointments to its Board of Directors and Scientific Advisory Board, as well as the formation of a Research and Development Committee.</p>\n\n<p>The company revealed early Monday that it had appointed Dr. Robert Lenz, Ms. Xin Liu, and Dr. Sean Cao to its Board of Directors. Additionally, I-Mab announced the formation of a Research and Development Committee and the appointment of Dr. Ken Takeshita to its Scientific Advisory Board. While these changes were positioned as enhancements to the company's expertise and strategic focus, investors appeared to react negatively to the news.</p>\n\n<p>The sharp decline in I-Mab's stock price suggests that the market may be uncertain about how these leadership changes will impact the company's future direction and performance. Investors might be concerned about potential shifts in strategy or execution that could result from the new appointments. Despite the company's emphasis on strengthening its R&D capabilities and board expertise, the market's immediate reaction indicates a level of skepticism or caution among shareholders.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | I-Mab Shares Plummet 5.30% Following Board and Advisory Appointments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | I-Mab Shares Plummet 5.30% Following Board and Advisory Appointments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-26 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, plummeted 5.30% during intraday trading on Monday, following the announcement of new appointments to its Board of Directors and Scientific Advisory Board, as well as the formation of a Research and Development Committee.</p>\n\n<p>The company revealed early Monday that it had appointed Dr. Robert Lenz, Ms. Xin Liu, and Dr. Sean Cao to its Board of Directors. Additionally, I-Mab announced the formation of a Research and Development Committee and the appointment of Dr. Ken Takeshita to its Scientific Advisory Board. While these changes were positioned as enhancements to the company's expertise and strategic focus, investors appeared to react negatively to the news.</p>\n\n<p>The sharp decline in I-Mab's stock price suggests that the market may be uncertain about how these leadership changes will impact the company's future direction and performance. Investors might be concerned about potential shifts in strategy or execution that could result from the new appointments. Despite the company's emphasis on strengthening its R&D capabilities and board expertise, the market's immediate reaction indicates a level of skepticism or caution among shareholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1100375914","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100375914","pubTimestamp":1756152026,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, plummeted 5.30% during intraday trading on Monday, following the announcement of new appointments to its Board of Directors and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"个股追踪|董事会和顾问任命后，天境生物股价暴跌5.30%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMAB":1},"content_text":"Shares of I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, plummeted 5.30% during intraday trading on Monday, following the announcement of new appointments to its Board of Directors and Scientific Advisory Board, as well as the formation of a Research and Development Committee.\nThe company revealed early Monday that it had appointed Dr. Robert Lenz, Ms. Xin Liu, and Dr. Sean Cao to its Board of Directors. Additionally, I-Mab announced the formation of a Research and Development Committee and the appointment of Dr. Ken Takeshita to its Scientific Advisory Board. While these changes were positioned as enhancements to the company's expertise and strategic focus, investors appeared to react negatively to the news.\nThe sharp decline in I-Mab's stock price suggests that the market may be uncertain about how these leadership changes will impact the company's future direction and performance. Investors might be concerned about potential shifts in strategy or execution that could result from the new appointments. Despite the company's emphasis on strengthening its R&D capabilities and board expertise, the market's immediate reaction indicates a level of skepticism or caution among shareholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}